Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
Journal of Egyptian National Cancer Institute/Journal of the Egyptian National Cancer Institute